A carregar...

Cell and Gene Therapies for Refractory Epilepsy

Despite recent advances in the development of antiepileptic drugs, refractory epilepsy remains a major clinical problem affecting up to 35% of patients with partial epilepsy. Currently, there are few therapies that affect the underlying disease process. Therefore, novel therapeutic concepts are urge...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Autor principal: Detlev, Boison
Formato: Artigo
Idioma:Inglês
Publicado em: Bentham Science Publishers Ltd. 2007
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2435346/
https://ncbi.nlm.nih.gov/pubmed/18615179
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!